Cerevance, a pharmaceutical company focusing on central nervous system diseases, has developed a new process for peering into the gene expression of specific brain cells. Their Nuclear Enriched Transcript Sort sequencing (NETSseq) platform can leverage a technique to specifically sort and isolate specific types of brain cells to more closely study each type.
Improving How Neurological Drugs are Developed Using Cell-Type-Specific Analysis
By Michael Tattory|
2019-10-21T12:33:03-04:00
October 9th, 2019|News|Comments Off on Improving How Neurological Drugs are Developed Using Cell-Type-Specific Analysis